CONTENTS:
• Role of cigarette sensory cues in modifying puffing topography. Rees V.W., Kreslake J.M., Wayne G.F., O’Connor R.J., Cummings K.M., Connolly G.N., p. 1-10.
• Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: A novel treatment strategy. Lee T.H., Szabo S.T., Fowler J.C., Mannelli P., Mangum O.B., Beyer W.F., et al., p. 11-18.
• Emerging psychoactive substance use among regular ecstasy users in Australia. Bruno R., Matthews A.J., Dunn M., Alati R., McIlwraith F., Hickey S., et al., p. 19-25.
• Patterns of alternative tobacco use among adolescent cigarette smokers. Nasim A., Blank M.D., Cobb C.O., Eissenberg T., p. 26-33.
• The importance of family factors to protect against substance use related problems among Mexican heritage and White youth. Kopak A.M., Chen A.C.-C., Haas S.A., Gillmore M.R., p. 34-41.
• The H2O2 scavenger ebselen decreases ethanol-induced locomotor stimulation in mice. Ledesma J.C., Font L., Aragon C.M.G., p. 42-49.
• Gender differences in the factor structure of the Alcohol Use Disorders Identification Test in multinational general population surveys. Peng C.-Z., Wilsnack R.W., Kristjanson A.F., Benson P., Wilsnack S.C., p. 50-56.
• Remission from alcohol and other drug problem use in public and private treatment samples over seven years. Delucchi K.L., Simon A.H.K., Weisner C., p. 57-62.
• A new criterion for acquisition of nicotine self-administration in rats. Peartree N.A., Sanabria F., Thiel K.J., Weber S.M., Cheung T.H.C., Neisewander J.L., p. 63-69.
• Prevalence of psychiatric disorders among young injection drug users. Mackesy-Amiti M.E., Donenberg G.R., Ouellet L.J., p. 70-78.
• “Unplugged”: A school-based randomized control trial to prevent and reduce adolescent substance use in the Czech Republic. Gabrhelik R., Duncan A., Miovsky M., Furr-Holden C.D.M., Stastna L., Jurystova L., p. 79-87.
• DSM-IV alcohol abuse and dependence criteria characteristics for recent onset adolescent drinkers. Rose J.S., Lee C.-T., Selya A.S., Dierker L.C., p. 88-94.
• Are females who inject drugs at higher risk for HIV infection than males who inject drugs: An international systematic review of high seroprevalence areas. Des Jarlais D.C., Feelemyer J.P., Modi S.N., Arasteh K., Hagan H., p. 95-107.
• Patterns of heroin and cocaine injection and plasma HIV-1 RNA suppression among a long-term cohort of injection drug users. Kerr T., Marshall B.D.L., Milloy M.J., Zhang R., Guillemi S., Montaner J.S.G., et al., p. 108-112.
• Former heroin addicts with or without a history of cocaine dependence are more impulsive than controls. Nielsen D.A., Ho A., Bahl A., Varma P., Kellogg S., Borg L., et al., p. 113-120.
• Tobacco advertising, environmental smoking bans, and smoking in Chinese urban areas. Yang T., Rockett I.R.H., Li M., Xu X., Gu Y., p. 121-127.
• The relationship between cannabis use disorders and social anxiety disorder in the National Epidemiological Study of Alcohol and Related Conditions (NESARC). Buckner J.D., Heimberg R.G., Schneier F.R., Liu S.-M., Wang S., Blanco C., p. 128-134.
• Differential effects of intermittent and continuous exposure to novel environmental stimuli on the development of amphetamine-induced behavioral sensitization in mice: Implications for addiction. Fukushiro D.F., Josino F.S., Saito L.P., Costa J.M., Zanlorenci L.H.F., Berro L.F., et al., p. 135-141.
• A voxel-based morphometry study comparing problem gamblers, alcohol abusers, and healthy controls. van Holst R.J., de Ruiter M.B., van den Brink W., Veltman D.J., Goudriaan A.E., p. 142-148.
• Escalation of methamphetamine self-administration in adolescent and adult rats. Anker J.J., Baron T.R., Zlebnik N.E., Carroll M.E., p. 149-153.
• Prevalence and trends of benzodiazepine use among Veterans Affairs patients with posttraumatic stress disorder, 2003–2010. Hawkins E.J., Malte C.A., Imel Z.E., Saxon A.J., Kivlahan D.R., p. 154-161.
• Improving treatment enrollment and re-enrollment rates of syringe exchangers: 12-Month outcomes. Kidorf M., King V.L., Gandotra N., Kolodner K., Brooner R.K., p. 162-166.
• Comparison of cognitive performance in methadone maintenance patients with and without current cocaine dependence. Henry P.K., Umbricht A., Kleykamp B.A., Vandrey R., Strain E.C., Bigelow G.E., et al., p. 167-171.
• Prevalence and trends of non-medical opioid and other drug use histories among federal correctional inmates in methadone maintenance treatment in Canada. Johnson S., MacDonald S.F., Cheverie M., Myrick C., Fischer B., p. 172-176.
• Lifetime ATS use and increased HIV risk among not-in-treatment opiate injectors in Malaysia. Chawarski M.C., Vicknasingam B., Mazlan M., Schottenfeld R.S., p. 177-180.
• Premorbid and current neuropsychological function in opiate abusers receiving treatment. Pluck G., Lee K.-H., Rele R., Spence S.A., Sarkar S., Lagundoye O., et al., p. 181-184.
• Does co-morbid depression alter the inverse relationship between obesity and substance use disorders? Gearhardt A.N., Harrison E.L.R., McKee S.A., p. 185-188.